Borderline Personality Disorder Clinical Trial
Official title:
Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder
| Verified date | April 2007 |
| Source | Hospices Civils de Lyon |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | France: Ministry of Health |
| Study type | Interventional |
This is a randomised trial comparing cognitive therapy and supportive therapy administered
along one year in borderline personality disorder. The follow-up is one year after
treatments end.
The therapists were the same in the two groups. Patients received one session a week during
six months and one session every two weeks during the next six months
| Status | Active, not recruiting |
| Enrollment | 70 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | |
| Gender | Both |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - DSM-4 DIBR >=8 (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Diagnostic inventory for borderline-revised) |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind
| Country | Name | City | State |
|---|---|---|---|
| France | Hopital Pierre Wertheimer | Bron |
| Lead Sponsor | Collaborator |
|---|---|
| Hospices Civils de Lyon |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Clinical Global Impression (CGI): Improvement (1-7): score 3 ( a little better) associated with a hopelessness scale score < 8 (this means that the suicide risk is low) | |||
| Secondary | CGI severity and improvement | |||
| Secondary | Hamilton depression | |||
| Secondary | Beck Depression Inventory | |||
| Secondary | Hopelessness | |||
| Secondary | Young: Schema Questionnaire II | |||
| Secondary | Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Personality Disorders Personality Questionnaire (SCID II PQ) | |||
| Secondary | Minnesota Multiphasic Personality Inventory (MMPI) (minimult) | |||
| Secondary | Eysenck: impulsivity scale | |||
| Secondary | Checklist: impulsive risky behaviors | |||
| Secondary | Quality of life | |||
| Secondary | Handicap (Sheehan) | |||
| Secondary | Time: Pre test, six months, post test and one year post treatment follow-up | |||
| Secondary | Therapeutic relationship evaluation scale (patients and therapists) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
| Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
| Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
| Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
| Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
| Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
| Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
| Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
| Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
| Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
| Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
| Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
| Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
| Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
| Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
| Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
| Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
| Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
| Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |